Valiant Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 51.68 | 58.42 | 35.89 |
| Operating Expense | 48.65 | 53.94 | 34.60 |
| Net Profit | 1.82 | 3.24 | 1.60 |
| Net Profit Margin | 3.52 | 5.55 | 4.46 |
| Earning Per Share | 0.42 | 0.74 | 0.37 |
| EBIDTA | 2.98 | 3.86 | 2.17 |
| Effective Tax Rate | 19.14 | 1.34 | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 51.68 |
| Operating Expense | 48.65 |
| Net Profit | 1.82 |
| Net Profit Margin | 3.52 |
| Earning Per Share | 0.42 |
| EBIDTA | 2.98 |
| Effective Tax Rate | 19.14 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 133.36 | 182.05 | 333.91 |
| Operating Expenses Annual | 138.04 | 190.46 | 298.82 |
| Operating Profit Annual | 0.75 | 1.27 | 39.95 |
| Interest Annual | 0.18 | 0.08 | 0.25 |
| Depreciation | 2.02 | 1.95 | 1.56 |
| Net Profit Annual | -2.15 | 0.34 | 29.00 |
| Tax Annual | 0.70 | -1.09 | 9.14 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 133.36 |
| Operating Expenses Annual | 138.04 |
| Operating Profit Annual | 0.75 |
| Interest Annual | 0.18 |
| Depreciation | 2.02 |
| Net Profit Annual | -2.15 |
| Tax Annual | 0.70 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 2.23 | 0.38 | 0.13 |
| Cash Flow from Operations | -21.90 | 48.78 | 22.96 |
| Cash Flow from Investing | 24.97 | -182.73 | -21.18 |
| Cash Flow from Financing | -0.50 | 135.80 | -1.53 |
| Cash Flow at the End | 4.80 | 2.23 | 0.38 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 2.23 |
| Cash Flow from Operations | -21.90 |
| Cash Flow from Investing | 24.97 |
| Cash Flow from Financing | -0.50 |
| Cash Flow at the End | 4.80 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | -0.82 | -1.05 | 11.96 |
| PBIT Margin (%) | -2.33 | -2.13 | 11.50 |
| PBT Margin (%) | 10.66 | 24.45 | -34.49 |
| Net PROFIT Margin (%) | -1.61 | 0.19 | 8.68 |
| Return On Networth / Equity (%) | -1.40 | -1.70 | 33.73 |
| Return On Networth /Employed (%) | -1.05 | -1.68 | 26 |
| Return On Assets (%) | -0.73 | 0.15 | 19.63 |
| Total Debt / Equity (X) | 0.25 | 0.36 | 0.71 |
| Asset Turnover Ratio (%) | 0.45 | 0.79 | 2.26 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | -0.82 |
| PBIT Margin (%) | -2.33 |
| PBT Margin (%) | 10.66 |
| Net PROFIT Margin (%) | -1.61 |
| Return On Networth / Equity (%) | -1.40 |
| Return On Networth /Employed (%) | -1.05 |
| Return On Assets (%) | -0.73 |
| Total Debt / Equity (X) | 0.25 |
| Asset Turnover Ratio (%) | 0.45 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 30.02 | 31.61 | 29.97 |
| Total Current Assets Annual | 119.22 | 209.27 | 181.96 |
| Non Current Assets Annual | 198.06 | 115.46 | 30.80 |
| Total Shareholders Funds Annual | 234.38 | 236.88 | 100.49 |
| Total Assets Annual | 317.28 | 324.73 | 212.76 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 30.02 |
| Total Current Assets Annual | 119.22 |
| Non Current Assets Annual | 198.06 |
| Total Shareholders Funds Annual | 234.38 |
| Total Assets Annual | 317.28 |
EPS (INR)
Expected
0.42
Reported
0.42
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
